Global Bead-Based Flow Cytometry Market, By Products (Reagents and Consumables, Flow Cytometry Instruments, Accessories, Services), Application (Research Applications, Clinical Application, Industrial Applications), End User (Academic & Research Institutes Pharmaceutical & Biotechnology Companies, Hospitals, Clinical Testing Laboratories, Blood Bank, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027
Bead-based flow cytometry market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to grow at a CAGR of 6.60% in the above-mentioned forecast period. Rising incidence and prevalence of HIV/AIDS and cancer drives the bead-based flow cytometry market.
Flow cytometry is a type of biophysical, laser-based analytical technology which measures and analyses numerous physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. It has several advantages over traditional analytical methods such as ELISA, that includes its ability to deliver precise and accurate results, and lesser time consumption at about same prices. It is extensively used in various fields of academic and clinical research, and diagnosis of diseases such as HIV, cancer and hematological malignancies.
Increasing public-private initiatives in the field of immunology and immuno-oncology research is the vital factor escalating the market growth, also availability of application-specific products, rising adoption of flow cytometry techniques in research and academia and hiking incorporation of AI platforms in flow cytometry workflows and advancements in flow cytometry software along with technological advancements are the major factors among others driving the bead-based flow cytometry market. Moreover, evolving pipeline for stem cell research and adoption of recombinant DNA technology for antibody production will further create new opportunities for bead-based flow cytometry market in the forecasted period of 2020-2027.
However, dearth of well-trained and skilled professionals, complexities related to reagent development, significant product costs and restricted purchasing power of end users are the major factors among others acting as restraints, and will further challenge the growth of bead-based flow cytometry market in the forecast period mentioned above.
The bead-based flow cytometry market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on bead-based flow cytometry market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Bead-Based Flow Cytometry Market Scope and Market Size
Bead-based flow cytometry market is segmented on the basis of products, application and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the bead-based flow cytometry market is segmented into reagents and consumables, flow cytometry instruments, accessories and services. The segment reagents and consumables are further sub-segmented into dyes, antibodies, beads and others. The segment flow cytometry instruments are further sub-segmented into cell analyzers and cell sorters. The segment services are further sub-segmented into filters, laser devices, detectors and others.
- Based on application, the bead-based flow cytometry market is segmented into research applications, clinical application, industrial applications. Research applications market is further sub-segmented into pharmaceutical and biotechnology, apoptosis, immunology, cell sorting/ screening, cell cycle analysis, cell transfection/viability, cell counting and others. The clinical application are further sub-segmented into cancer, hematology, immunodeficiency diseases, organ transplantation, and others.
- The bead-based flow cytometry market is also segmented on the basis of end-user into academic and research institutes pharmaceutical and biotechnology companies, hospitals, clinical testing laboratories, blood bank and others.
Bead-Based Flow Cytometry Market Country Level Analysis
Bead-based flow cytometry market is analysed and market size insights and trends are provided by country, products, application and end-user as referenced above.
The countries covered in the bead-based flow cytometry market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the bead-based flow cytometry market due to availability of supportive government reforms for the development of advanced technologies for molecular diagnostics, presence of a large number of clinical research labs and major pharmaceuticals in the U.S. Asia-Pacific is the expected region in terms of growth in bead-based flow cytometry market due to constantly improving healthcare infrastructure, supportive government funding for the biotech industry development and presence of untapped opportunities, rapid economic development, and rising patient awareness levels.
The country section of the bead-based flow cytometry market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Bead-based flow cytometry market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for bead-based flow cytometry market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bead-based flow cytometry market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Bead-Based Flow Cytometry Market Share Analysis
Bead-based flow cytometry market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to bead-based flow cytometry market.
The major players covered in the bead-based flow cytometry market report are Miltenyi Biotec Sysmex Partec GmbH, BIOMÉRIEUX, Bio-Rad Laboratories, Inc., Mechatronics, Apogee Flow Systems Ltd., Stratedigm, Inc., Sony Biotechnology Inc., BD., Thermo Fisher Scientific Inc., Merck KGaA, ACEA BIO, Agilent Technologies, Luminex Corporation., Enzo Life Sciences, Inc., Beckman Coulter, Inc., Takara Bio Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Bead-Based Flow Cytometry Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.